In 2019, the European Multiple Sclerosis Platform marks its 30 years of raising the voice of people with Multiple Sclerosis in Europe.

At the eve of the European elections, the MS patient community will be gathering in Vilnius, capital of Lithuania for EMSP’s Annual General Meeting (Thursday 9th May 2019, Members only) and EMSP’s Annual Conference (Friday 10th and Saturday 11th May 2019).

We look forward to welcoming you for what promises to be yet another insightful conference with high-powered networking sessions and impactful keynote presentations. The EMSP conferences represent a valuable forum for the exchange and sharing of knowledge and experience in the field of multiple sclerosis.

We encourage individual patients, patient organisations, healthcare professionals, researchers, public health officials, policy-makers and the industry – at the national, regional and European level – to attend this Conference.

Be part of the discussion and help us shape the MS landscape!


Register before February 15th, 2019 and benefit from the early bird rate. Registration can be done via the link available on the conference website:

EMSP Members and residents from the Baltic states and Belarus can benefit from favourable rates.


EMSP has negotiated favourable room rates at the conference venue (available until 15 Feb 2019 only). The rooms need to be booked and paid on the conference booking system by the individual delegate.


The theme of the 2019 EMSP Annual Conference is: Digital Health in MS Management.

First programme highlights:

  • Members’ clinical research workshop by the European Centre for Clinical Research Training;
  • Public sessions on:
    • Setting the scene and priorities in digital health in MS Management: EU policy, research involvement, rehabilitation and patient-centricity;
    • Research and innovation in digital health for MS;
    • Digital health in MS: geographical and generational gaps;
    • Digital health and PRO: to influence decision-making processes (pricing, reimbursement, QoL indicators);
  • Testimonials from people with MS.